An ergot derivative in the treatment of Parkinson's disease.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000037:antagonists & inhibitors; D001971:Bromocriptine / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004873:Ergolines / Q000627:therapeutic use*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy*
D004873:Ergolines; D001971:Bromocriptine; D007980:Levodopa; D015105:3',5'-Cyclic-AMP Phosphodiesterases